» Articles » PMID: 39609832

The Role of Cerebrospinal Fluid Metabolites in Mediating the Impact of Lipids on Late-Onset Alzheimer's Disease: a Two-step Mendelian Randomization Analysis

Overview
Journal J Transl Med
Publisher Biomed Central
Date 2024 Nov 28
PMID 39609832
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Although research has indicated correlations between lipids, cerebrospinal fluid (CSF) metabolites, and Late-Onset Alzheimer's Disease (LOAD), the specific causal relationships among these elements, as well as the roles and mechanisms of the cerebrospinal fluid metabolites, remain unclear.

Methods: Statistical datasets derived from Genome-Wide Association Studies (GWAS) were utilized to assess the bidirectional causal relationships between lipids and LOAD. Subsequently, genetic variants associated with CSF metabolites and established lipids underwent a two-step Mendelian randomization (MR) analysis to explore potential mediators and analyze mediation effects. Sensitivity analyses were employed to assess the robustness of the detection systems.

Results: Genetically predicted cholesterol (IVW OR = 0.989; 95% CI 0.982-0.996) was found to reduce the risk of LOAD, whereas Phosphatidylcholine (PC) (18:1_0:0) (IVW OR = 1.015; 95% CI 1.005-1.025) posed a risk factor. The potential mediator, CSF metabolite N-acetylneuraminate (NeuAC), was identified with a mediation proportion of 21.02% (3.25%, 45.50%). No pleiotropy or heterogeneity was detected across MR analyses.

Conclusions: The findings underscore the pivotal role of CSF metabolomics in elucidating the lipid-mediated pathogenesis of LOAD, highlighting potential diagnostic and preventative biomarkers.

References
1.
Burgess S, Butterworth A, Thompson S . Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013; 37(7):658-65. PMC: 4377079. DOI: 10.1002/gepi.21758. View

2.
Zhang S, Yue Z, Arnold D, Artiushin G, Sehgal A . A Circadian Clock in the Blood-Brain Barrier Regulates Xenobiotic Efflux. Cell. 2018; 173(1):130-139.e10. PMC: 5866247. DOI: 10.1016/j.cell.2018.02.017. View

3.
Shimomura Y, Kitaura Y . Physiological and pathological roles of branched-chain amino acids in the regulation of protein and energy metabolism and neurological functions. Pharmacol Res. 2018; 133:215-217. DOI: 10.1016/j.phrs.2018.05.014. View

4.
Baron R, Kenny D . The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986; 51(6):1173-82. DOI: 10.1037//0022-3514.51.6.1173. View

5.
Wolozin B, Kellman W, Ruosseau P, CELESIA G, Siegel G . Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol. 2000; 57(10):1439-43. DOI: 10.1001/archneur.57.10.1439. View